PegIFN Alpha-2A Reduces Relapse in HBeAg-negative Patients after Nucleo(s)tide Analogue Cessation: A Randomized-Controlled Trial
Journal of hepatology(2024)
Key words
chronic hepatitis B,HBeAg-negative,interferon alpha-2a,relapse,randomized controlled trial,treatment cessation
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined